Adaptive Biotechnologies vs Caris Life Sciences
Adaptive Biotechnologies vs Caris Life Sciences, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Caris Life Sciences on 59/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 59/100
Caris Life Sciences
- agent readiness: 47/100 against 39/100
- funding raised: $700M against $300M
At a glance
| Measure | Adaptive Biotechnologies | Caris Life Sciences |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Services |
| Founded | 2009 | 2008 |
| Headquarters | Seattle, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Caris Life Sciences |
|---|---|---|
| Employees | Not published | 1,659 |
| Total funding | $300M | $700M |
| Latest round | Series D | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | Not published | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 59/100 |
| Traction | Not published | 60/100 |
| Search visibility | Not published | 22/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Caris Life Sciences |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Adaptive Biotechnologies vs Caris Life Sciences: common questions
Which is better, Adaptive Biotechnologies or Caris Life Sciences?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Caris Life Sciences compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 59/100). Caris Life Sciences leads on agent readiness (47/100 against 39/100), funding raised ($700M against $300M).
Read the full Adaptive Biotechnologies review and pricing or the Caris Life Sciences review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.